Selected article for: "acute sars and low incidence"
Author: Bogogiannidou, Zacharoula; Vontas, Alexandros; Dadouli, Katerina; Kyritsi, Maria A; Soteriades, Soteris; Nikoulis, Dimitrios J; Mouchtouri, Varvara Α; Koureas, Michalis; Kazakos, Evangelos I; Spanos, Emmanouil G; Gioula, Georgia; Ntzani, Evangelia E; Eleftheriou, Alexandros A; Vatopoulos, Alkiviadis; Petinaki, Efthimia; Papaevangelou, Vassiliki; Speletas, Matthaios; Tsiodras, Sotirios; Hadjichristodoulou, Christos
Title: Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020
  • Cord-id: a0mp5z5h
  • Document date: 2020_8_6
    • ID: a0mp5z5h
    Snippet: A serosurvey of IgG antibodies against severe acute respiratory coronavirus 2 (SARS-CoV-2) was performed during March and April 2020. Among 6,586 leftover sera, 24 (0.36%) were positive, with higher prevalence in females, older individuals and residents of large urban areas. Seroprevalence was estimated at 0.02% and 0.25%, respectively, in March and April, infection fatality rate at 2.66% and 0.54%. Our findings confirm low COVID-19 incidence in Greece and possibly the effectiveness of early mea
    Document: A serosurvey of IgG antibodies against severe acute respiratory coronavirus 2 (SARS-CoV-2) was performed during March and April 2020. Among 6,586 leftover sera, 24 (0.36%) were positive, with higher prevalence in females, older individuals and residents of large urban areas. Seroprevalence was estimated at 0.02% and 0.25%, respectively, in March and April, infection fatality rate at 2.66% and 0.54%. Our findings confirm low COVID-19 incidence in Greece and possibly the effectiveness of early measures.

    Search related documents:
    Co phrase search for related documents
    • abbott assay and low seroprevalence: 1, 2, 3, 4, 5
    • active case and low consider: 1